BX Swiss TOP 30 CHF
1.376,73
PKT
-7,97
PKT
-0,58
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.02.12 | Straumann neutral | Sarasin Research | |
| 22.02.12 | Zurich Insurance hold | Commerzbank Corp. & Markets | |
| 22.02.12 | Holcim hold | Deutsche Bank AG | |
| 21.02.12 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 21.02.12 | Schindler buy | Sarasin Research | |
| 21.02.12 | Givaudan neutral | Credit Suisse Group | |
| 21.02.12 | ABB (Asea Brown Boveri) outperform | Cheuvreux SA | |
| 21.02.12 | Swisscom buy | Nomura | |
| 21.02.12 | Julius Bär buy | Sarasin Research | |
| 21.02.12 | Zurich Insurance outperform | RBC Capital Markets | |
| 21.02.12 | Zurich Insurance halten | Independent Research GmbH | |
| 20.02.12 | Holcim neutral | Citigroup Corp. | |
| 20.02.12 | Zurich Insurance buy | ING | |
| 20.02.12 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.02.12 | UBS halten | Hamburger Sparkasse AG (Haspa) | |
| 20.02.12 | Nestlé halten | Independent Research GmbH | |
| 20.02.12 | Givaudan neutral | UBS AG | |
| 17.02.12 | Zurich Insurance neutral | Merrill Lynch & Co., Inc. | |
| 17.02.12 | Givaudan sell | Citigroup Corp. | |
| 17.02.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 17.02.12 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 17.02.12 | Zurich Insurance buy | Nomura | |
| 17.02.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 16.02.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 16.02.12 | Nestlé hold | ING | |
| 16.02.12 | Zurich Insurance buy | Sarasin Research | |
| 16.02.12 | Givaudan neutral | Sarasin Research | |
| 15.02.12 | Swisscom neutral | Sarasin Research | |
| 15.02.12 | Swiss Re equal-weight | Morgan Stanley | |
| 14.02.12 | UBS underperform | Exane-BNP Paribas SA | |
| 14.02.12 | UBS underperform | Exane-BNP Paribas SA | |
| 14.02.12 | Roche neutral | Citigroup Corp. | |
| 14.02.12 | Geberit halten | Öko Invest | |
| 14.02.12 | UBS overweight | HSBC | |
| 14.02.12 | UBS overweight | HSBC | |
| 13.02.12 | Zurich Insurance neutral | UBS AG | |
| 13.02.12 | ABB (Asea Brown Boveri) buy | ING | |
| 13.02.12 | UBS neutral | UBS AG | |
| 13.02.12 | Zurich Insurance buy | ING | |
| 10.02.12 | UBS halten | Independent Research GmbH |